Who owns TSCAN THERAPEUTICS INC?
- Ticker: TCRX
- CUSIP Number: 89854m101
Tip: Access positions for across all investors
Analyze quarterly positions in Tscan Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tscan Therapeutics stock
Who bought or sold TSCAN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lynx1 Capital Management | 8.0M | $8.0M | 2% | Dec 2025 |
|
| BVF | 5.2M | $9.5M | 0% | Sep 2025 |
|
| Baker Bros. Advisors | 2.8M | $5.1M | 0% | Sep 2025 |
|
| Vanguard Group | 2.5M | $2.5M | 7% | Dec 2025 |
|
| BlackRock | 1.8M | $1.8M | -22% | Dec 2025 |
|
| Standard Life Aberdeen | 1.8M | $1.8M | 32% | Dec 2025 |
|
| Deer Management | 1.2M | $1.2M | 0% | Dec 2025 |
|
| Renaissance Technologies | 1.1M | $1.1M | 37% | Dec 2025 |
|
| DC Funds | 630k | $630M | 0% | Dec 2025 |
|
| Geode Capital Management | 562k | $562k | -1% | Dec 2025 |
|
| Millennium Management | 466k | $848k | -26% | Sep 2025 |
|
| Two Sigma Investments | 419k | $763k | 15% | Sep 2025 |
|
| Citadel Advisors | 391k | $711k | 78% | Sep 2025 |
|
| Jane Street | 388k | $388k | 378% | Dec 2025 |
|
| Marshall Wace | 339k | $339k | 628% | Dec 2025 |
|
| Two Sigma Advisers | 289k | $526k | 35% | Sep 2025 |
|
| Jpmorgan Chase & Co | 238k | $433k | 100% | Sep 2025 |
|
| GSA Capital Partners | 226k | $226k | 100% | Dec 2025 |
|
| XTX Topco | 219k | $219k | 1142% | Dec 2025 |
|
| Susquehanna International | 216k | $216k | 171% | Dec 2025 |
|
| State Street Corporation | 207k | $207k | 5% | Dec 2025 |
|
| Jacobs Levy Equity Management | 188k | $188k | 100% | Dec 2025 |
|
| Brown Brothers Harriman & Co. | 143k | $143k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 140k | $256k | -9% | Sep 2025 |
|
| Northern Trust | 98k | $98k | 0% | Dec 2025 |
|
| Letko, Brosseau & Associates | 96k | $96k | 0% | Dec 2025 |
|
| NewEdge Wealth | 92k | $92k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 87k | $87k | -34% | Dec 2025 |
|
| Dimensional Fund Advisors | 75k | $75k | -15% | Dec 2025 |
|
| Stifel Financial | 72k | $72k | -26% | Dec 2025 |
|
| UBS Group | 55k | $55k | 398% | Dec 2025 |
|
| Voleon Capital Management | 48k | $87k | 100% | Sep 2025 |
|
| Tang Capital Management | 46k | $46k | -92% | Dec 2025 |
|
| Cubist Systematic Strategies | 42k | $77k | -76% | Sep 2025 |
|
| Dean Capital Investments Management | 36k | $36k | 0% | Dec 2025 |
|
| Acadian Asset Management | 30k | $28k | 100% | Dec 2025 |
|
| Algert Coldiron Investors | 28k | $51k | 0% | Sep 2025 |
|
| Hrt Financial | 27k | $26k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 26k | $26k | -12% | Dec 2025 |
|
| PanAgora Asset Management | 25k | $25k | 100% | Dec 2025 |
|
| Hsbc Holdings | 25k | $44k | -19% | Sep 2025 |
|
| Prudential Financial | 24k | $24k | 112% | Dec 2025 |
|
| Barclays | 23k | $23k | 22% | Dec 2025 |
|
| LPL Financial | 23k | $23k | 5% | Dec 2025 |
|
| Neuberger Berman Group | 18k | $18k | 0% | Dec 2025 |
|
| R Squared | 16k | $16k | -15% | Dec 2025 |
|
| Two Sigma Securities | 16k | $16k | 100% | Dec 2025 |
|
| JustInvest | 15k | $15k | -30% | Dec 2025 |
|
| Point72 Asia | 15k | $27k | -50% | Sep 2025 |
|
| Point72 Asset Management | 15k | $15k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 12k | $12k | 0% | Dec 2025 |
|
| Waldron | 10k | $10k | 0% | Dec 2025 |
|
| Aries Wealth Management | 10k | $10k | 0% | Dec 2025 |
|
| Mizuho Securities Usa | 10k | $10k | 100% | Dec 2025 |
|
| FMR | 10k | $18k | -8% | Sep 2025 |
|
| Tower Research Capital | 6.8k | $6.8k | -39% | Dec 2025 |
|
| Federated Investors | 5.0k | $5.0k | 129% | Dec 2025 |
|
| Royal Bank of Canada | 806.00 | $0 | 1068% | Sep 2025 |
|
| SBI Securities | 392.00 | $392.000000 | 85% | Dec 2025 |
|
| Strategic Wealth Partners | 311.00 | $565.988900 | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 200.00 | $200.000000 | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 8.00 | $8.000000 | 100% | Dec 2025 |
|
Who sold out of Tscan Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Propel Bio Management | Sep 2025 | 1.9M | $3.5M |
| Alphabet | Sep 2025 | 1.1M | $2.0M |
| Simplify Asset Management | Sep 2025 | 905k | $1.6M |
| Militia Capital Partners | Sep 2025 | 102k | $186k |
| Virtu Financial | Sep 2025 | 61k | $110k |
| Catalyst Funds Management Pty | Sep 2025 | 31k | $56k |
| Qube Research & Technologies | Sep 2025 | 28k | $50k |
| AQR Capital Management | Jun 2025 | 22k | $33k |
| Mariner Wealth Advisors | Sep 2025 | 16k | $29k |
| China Universal Asset Management | Sep 2025 | 9.2k | $17k |
| Mirae Asset Global Investments | Sep 2025 | 2.0k | $3.7k |
| Gf Fund Management | Sep 2025 | 1.0k | $1.9k |
| NISA Investment Advisors | Sep 2025 | 593.00 | $1.1k |
| Rialto Wealth Management | Sep 2025 | 381.00 | $693.991500 |
| EverSource Wealth Advisors | Sep 2025 | 65.00 | $118.001000 |
| Atlas Capital Advisors | Jun 2025 | 18.00 | $25.999200 |
| True Wealth Design | Sep 2025 | 9.00 | $17.000100 |
| CWM | Sep 2025 | 8.00 | $0 |